| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_129e393582e6bdf4029baf2206522f45 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-5412
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-204 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-20 |
| filingDate |
1992-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9aefff89b0fd90fee77ba51884427995
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3d984b19638fb10599bec37a66dee10d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6356daeac185825fb46f4d02e17d75ce
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1ef494491f8e85005b42d5492d87ac0c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e6e5cb786bea3c0519599ec17d80fec7 |
| publicationDate |
1993-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-9306840-A1 |
| titleOfInvention |
Medicine for preventing and treating bleeding tendency |
| abstract |
A medicine for preventing and treating bleeding tendency containing IL-6 as an active ingredient. The administration of IL-6 serves to enhance the functions of both blood platelets and hemangioendothelial cells to thereby remedy hemorrhagic diathesis, thus enhancing the hemostatic function. Thus IL-6 is useful as an excellent medicine for preventing and treating bleeding tendency, since it has an activity of efficiently inhibiting the bleeding tendency of a living organism and is $i(per se) a physiologically active substance derived from a living organism. Therefore IL-6 is useful in treating various bleeding tendencies, such as one caused by bone marrow inhibition after cancer chemotherapy and radiotherapy, one observed after bone marrow transplantation, one observed in hypoplastic anemia, or one observed in idiopathic thrombocytopenic purpura. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9323065-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9401123-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-4643783-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5635176-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2001181200-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9603143-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5582821-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5925344-A |
| priorityDate |
1991-10-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |